Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 1306 AL 1320

Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases

Gerhardt S, Mohajeri MH.

Nutrients. 2018 Jun 1;10(6):708. doi: 10.3390/nu10060708.

Difficult choices in treating Parkinson's disease psychosis

The Lancet Neurology.

Lancet Neurol. 2018 Jul;17(7):569. doi: 10.1016/S1474-4422(18)30209-6. Epub 2018 May 29.

Exercise for people with Parkinson's: a practical approach

Ramaswamy B, Jones J, Carroll C.

Pract Neurol. 2018 Oct;18(5):399-406. doi: 10.1136/practneurol-2018-001930. Epub 2018 Jun 1.

Lesson of the month 2: An unusual adverse reaction associated with pramipexole

Tashkent Y, Aiyappan V.

Clin Med (Lond). 2018 Jun;18(3):259-260. doi: 10.7861/clinmedicine.18-3-259.

Hippocampal subfield atrophy in patients with Parkinson's disease and psychosis

Lenka A, Ingalhalikar M, Shah A, Saini J, Arumugham SS, Hegde S, George L, Reddy V, Reddy YCJ, Yadav R, Pal PK.

J Neural Transm (Vienna). 2018 Sep;125(9):1361-1372. doi: 10.1007/s00702-018-1891-3. Epub 2018 Jun 1.

SNCA REP1 and Parkinson's disease

Shu L, Zhang Y, Sun Q, Pan H, Guo J, Tang B.

Neurosci Lett. 2018 Aug 24;682:79-84. doi: 10.1016/j.neulet.2018.05.043. Epub 2018 May 30.

Association between depression and the subsequent risk of Parkinson's disease: A meta-analysis

Wang S, Mao S, Xiang D, Fang C.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:186-192. doi: 10.1016/j.pnpbp.2018.05.025. Epub 2018 May 31.

RIT2: responsible and susceptible gene for neurological and psychiatric disorders

Daneshmandpour Y, Darvish H, Emamalizadeh B.

Mol Genet Genomics. 2018 Aug;293(4):785-792. doi: 10.1007/s00438-018-1451-4. Epub 2018 Jun 2.

Parkinson's Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care

Williams U, Bandmann O, Walker R.

J Mov Disord. 2018 May;11(2):53-64. doi: 10.14802/jmd.17028. Epub 2018 May 30.

A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress

Trist BG, Hare DJ, Double KL.

Cell Chem Biol. 2018 Jul 19;25(7):807-816. doi: 10.1016/j.chembiol.2018.05.004. Epub 2018 May 31.

Research Progress in the Effect of Traditional Chinese Medicine for Invigoration on Neurotransmitter Related Diseases

Zhang X, Li L, Chen T, Sun Z, Tang W, Wang S, Wang T, Wang Y, Zhang H.

Evid Based Complement Alternat Med. 2018 May 14;2018:4642018. doi: 10.1155/2018/4642018. eCollection 2018.

Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences

de Andrade Teles RB, Diniz TC, Costa Pinto TC, de Oliveira Júnior RG, Gama E Silva M, de Lavor ÉM, Fernandes AWC, de Oliveira AP, de Almeida Ribeiro FPR, da Silva AAM, Cavalcante TCF, Quintans Júnior LJ, da Silva Almeida JRG.

Oxid Med Cell Longev. 2018 May 10;2018:7043213. doi: 10.1155/2018/7043213. eCollection 2018.

Recent Trends in the Use of Electrical Neuromodulation in Parkinson's Disease

Brittain JS, Cagnan H.

Curr Behav Neurosci Rep. 2018;5(2):170-178. doi: 10.1007/s40473-018-0154-9. Epub 2018 Apr 24.

Dual Leucine Zipper Kinase Inhibitors for the Treatment of Neurodegeneration

Siu M, Sengupta Ghosh A, Lewcock JW.

J Med Chem. 2018 Sep 27;61(18):8078-8087. doi: 10.1021/acs.jmedchem.8b00370. Epub 2018 Jun 4.

Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function

Fan D, Alamri Y, Liu K, MacAskill M, Harris P, Brimble M, Dalrymple-Alford J, Prickett T, Menzies O, Laurenson A, Anderson T, Guan J.

Nutrients. 2018 Jun 2;10(6):714. doi: 10.3390/nu10060714.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias